These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31064116)

  • 1. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice.
    Aboumsallem JP; Muthuramu I; Mishra M; De Geest B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol lowering attenuates pressure overload-induced heart failure in mice with mild hypercholesterolemia.
    Muthuramu I; Mishra M; Aboumsallem JP; Postnov A; Gheysens O; De Geest B
    Aging (Albany NY); 2019 Sep; 11(17):6872-6891. PubMed ID: 31484164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.
    Muthuramu I; Amin R; Postnov A; Mishra M; Aboumsallem JP; Dresselaers T; Himmelreich U; Van Veldhoven PP; Gheysens O; Jacobs F; De Geest B
    Mol Ther; 2017 Nov; 25(11):2513-2525. PubMed ID: 28822689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
    Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
    Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice.
    Aboumsallem JP; Muthuramu I; Mishra M; Kempen H; De Geest B
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):39-50. PubMed ID: 28319449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
    Xu M; Wu X; Liu Z; Ding Y; Kong W; Little PJ; Xu S; Weng J
    Biochem Biophys Res Commun; 2022 Sep; 622():163-169. PubMed ID: 35868060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia.
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):28-38. PubMed ID: 28319445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
    Kassim SH; Li H; Vandenberghe LH; Hinderer C; Bell P; Marchadier D; Wilson A; Cromley D; Redon V; Yu H; Wilson JM; Rader DJ
    PLoS One; 2010 Oct; 5(10):e13424. PubMed ID: 20976059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS; Martins I; Davidson BL
    J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia.
    Chen SJ; Sanmiguel J; Lock M; McMenamin D; Draper C; Limberis MP; Kassim SH; Somanathan S; Bell P; Johnston JC; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):154-60. PubMed ID: 24070336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload.
    Amin R; Muthuramu I; Aboumsallem JP; Mishra M; Jacobs F; De Geest B
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitus.
    Le Quang K; Bouchareb R; Lachance D; Laplante MA; El Husseini D; Boulanger MC; Fournier D; Fang XP; Avramoglu RK; Pibarot P; Deshaies Y; Sweeney G; Mathieu P; Marette A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2283-91. PubMed ID: 25231636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
    Pan G; Munukutla S; Kar A; Gardinier J; Thandavarayan RA; Palaniyandi SS
    PLoS One; 2018; 13(4):e0195796. PubMed ID: 29677191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
    Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
    J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
    Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice.
    Heinonen SE; Merentie M; Hedman M; Mäkinen PI; Loponen E; Kholová I; Bosch F; Laakso M; Ylä-Herttuala S
    Cardiovasc Diabetol; 2011 Jun; 10():59. PubMed ID: 21718508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective homocysteine lowering gene transfer improves infarct healing, attenuates remodelling, and enhances diastolic function after myocardial infarction in mice.
    Muthuramu I; Jacobs F; Singh N; Gordts SC; De Geest B
    PLoS One; 2013; 8(5):e63710. PubMed ID: 23675503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction.
    Da Dalt L; Castiglioni L; Baragetti A; Audano M; Svecla M; Bonacina F; Pedretti S; Uboldi P; Benzoni P; Giannetti F; Barbuti A; Pellegatta F; Indino S; Donetti E; Sironi L; Mitro N; Catapano AL; Norata GD
    Eur Heart J; 2021 Aug; 42(32):3078-3090. PubMed ID: 34252181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.